Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to
progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by …

Transthyretin (TTR) is a tetrameric protein synthesized primarily by the liver. TTR can misfold
into pathogenic ATTR amyloid fibrils that deposit in the nerves and heart, causing a …

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

Objectives This study aimed to test the diagnostic value of [18F]–florbetaben positron
emission tomography (PET) in patients with suspicion of CA. Background Diagnosis of …

Aims The aim of this retrospective analysis was to examine the pattern of cardiac 68 Ga-
fibroblast-activation protein-α inhibitor (FAPI) uptake in patients after acute myocardial …

Pre-treatment survival prediction plays a key role in many diseases. We aimed to determine
the prognostic value of pre-treatment Magnetic Resonance Imaging (MRI) based radiomic …

Cardiac amyloidosis is caused by the extracellular deposition of amyloid fibrils in the heart,
involving not only the myocardium but also any cardiovascular structure. Indeed, this …

Purpose Transthyretin (ATTR) amyloidosis is a progressive protein misfolding disease with
frequent cardiac involvement. This review aims to determine the value of PET in diagnosis …

Cardiac amyloidosis (CA) is a disease characterized by the deposition of misfolded protein
deposits in the myocardial interstitium. Although advanced CA confers significant morbidity …

Background In-vivo cardiovascular magnetic resonance (CMR) diffusion tensor imaging
(DTI) allows imaging of alterations of cardiac fiber architecture in diseased hearts. Cardiac …